@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://smart.who.int/immunizations-measles/PlanDefinition/IMMZD2DTMeaslesSupplementary> a fhir:PlanDefinition ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "IMMZD2DTMeaslesSupplementary"] ; # 
  fhir:meta [
     fhir:profile ( [
       fhir:v "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition"^^xsd:anyURI ;
       fhir:link <http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition>
     ] [
       fhir:v "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareableplandefinition"^^xsd:anyURI ;
       fhir:link <http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareableplandefinition>
     ] [
       fhir:v "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishableplandefinition"^^xsd:anyURI ;
       fhir:link <http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishableplandefinition>
     ] )
  ] ; # 
  fhir:text [
     fhir:status [ fhir:v "extensions" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: PlanDefinition </b><a name=\"IMMZD2DTMeaslesSupplementary\"> </a><a name=\"hcIMMZD2DTMeaslesSupplementary\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourcePlanDefinition &quot;IMMZD2DTMeaslesSupplementary&quot; </p><p style=\"margin-bottom: 0px\">Profiles: <a href=\"https://build.fhir.org/ig/HL7/cqf-recommendations/StructureDefinition-cpg-recommendationdefinition.html\">CPG Recommendation Definition</a>, <a href=\"http://hl7.org/fhir/uv/crmi/STU1/StructureDefinition-crmi-shareableplandefinition.html\">CRMI Shareable PlanDefinition</a>, <a href=\"http://hl7.org/fhir/uv/crmi/STU1/StructureDefinition-crmi-publishableplandefinition.html\">CRMI Publishable PlanDefinition</a></p></div><p><b>CQF Knowledge capability</b>: computable</p><p><b>url</b>: <code>http://smart.who.int/immunizations-measles/PlanDefinition/IMMZD2DTMeaslesSupplementary</code></p><p><b>version</b>: 0.1.0</p><p><b>name</b>: IMMZD2DTMeaslesSupplementary</p><p><b>title</b>: IMMZ.D2.DT.Measles MCV Dose 0</p><p><b>type</b>: ECA Rule <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-plan-definition-type.html\">PlanDefinitionType</a>#eca-rule)</span></p><p><b>status</b>: draft</p><p><b>experimental</b>: true</p><p><b>date</b>: 2024-06-07 12:26:37+0000</p><p><b>publisher</b>: WHO</p><p><b>contact</b>: WHO: <a href=\"http://who.int\">http://who.int</a></p><p><b>description</b>: If the child or patient has not been given a supplementary dose</p><h3>RelatedArtifacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Citation</b></td></tr><tr><td style=\"display: none\">*</td><td>citation</td><td>WHO recommendations for routine immunization - summary tables (March 2023)</td></tr></table><p><b>library</b>: <a href=\"Library-IMMZD2DTMeaslesSupplementaryLogic.html\">IMMZD2DTMeaslesSupplementaryLogic</a></p><blockquote><p><b>action</b></p><p><b>title</b>: Immunize patient for Measles</p><blockquote><p><b>condition</b></p><p><b>kind</b>: applicability</p><h3>Expressions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style=\"display: none\">*</td><td>text/cql-identifier</td><td>Measles Routine Immunization Schedule Complete</td></tr></table></blockquote><blockquote><p><b>action</b></p><p><b>CPG Rationale Extension</b>: An additional dose of MCV should be administered to HIV-infected children receiving HAART following immune reconstitution. If CD4+ T lymphocyte counts are monitored, an additional dose of MCV should be administered when immune reconstitution has been achieved, e.g. when the CD4+ T lymphocyte count reaches 20–25%. Where CD4+ T lymphocyte monitoring is not available, children should receive an additional dose of MCV 6–12 months after initiation of HAART.&lt;br/&gt;As a general rule, live vaccines should be given either simultaneously or at intervals of 4 weeks. An exception to this rule is OPV, which can be given at any time before or after measles vaccination without interference in the response to either vaccine</p><p><b>title</b>: Consider supplementary dose</p><blockquote><p><b>condition</b></p></blockquote><blockquote><p><b>action</b></p></blockquote><blockquote><p><b>action</b></p></blockquote></blockquote><blockquote><p><b>action</b></p><p><b>title</b>: Supplementary Dose Administered</p><p><b>description</b>: Measles immunization schedule is complete. Measles supplementary dose was administered.</p><blockquote><p><b>condition</b></p></blockquote></blockquote></blockquote></div>"
  ] ; # 
  fhir:extension ( [
     fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability"^^xsd:anyURI ] ;
     fhir:value [ fhir:v "computable" ]
  ] ) ; # 
  fhir:url [ fhir:v "http://smart.who.int/immunizations-measles/PlanDefinition/IMMZD2DTMeaslesSupplementary"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "0.1.0"] ; # 
  fhir:name [ fhir:v "IMMZD2DTMeaslesSupplementary"] ; # 
  fhir:title [ fhir:v "IMMZ.D2.DT.Measles MCV Dose 0"] ; # 
  fhir:type [
     fhir:coding ( [
       fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/plan-definition-type"^^xsd:anyURI ] ;
       fhir:code [ fhir:v "eca-rule" ]
     ] )
  ] ; # 
  fhir:status [ fhir:v "draft"] ; # 
  fhir:experimental [ fhir:v "true"^^xsd:boolean] ; # 
  fhir:date [ fhir:v "2024-06-07T12:26:37+00:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "WHO"] ; # 
  fhir:contact ( [
     fhir:name [ fhir:v "WHO" ] ;
     fhir:telecom ( [
       fhir:system [ fhir:v "url" ] ;
       fhir:value [ fhir:v "http://who.int" ]
     ] )
  ] ) ; # 
  fhir:description [ fhir:v "If the child or patient has not been given a supplementary dose"] ; # 
  fhir:relatedArtifact ( [
     fhir:type [ fhir:v "citation" ] ;
     fhir:citation [ fhir:v "WHO recommendations for routine immunization - summary tables (March 2023)" ]
  ] ) ; # 
  fhir:library ( [
     fhir:v "http://smart.who.int/immunizations-measles/Library/IMMZD2DTMeaslesSupplementaryLogic"^^xsd:anyURI ;
     fhir:link <http://smart.who.int/immunizations-measles/Library/IMMZD2DTMeaslesSupplementaryLogic>
  ] ) ; # 
  fhir:action ( [
     fhir:title [ fhir:v "Immunize patient for Measles" ] ;
     fhir:condition ( [
       fhir:kind [ fhir:v "applicability" ] ;
       fhir:expression [
         fhir:language [ fhir:v "text/cql-identifier" ] ;
         fhir:expression [ fhir:v "Measles Routine Immunization Schedule Complete" ]
       ]
     ] ) ;
     fhir:action ( [
       fhir:extension ( [
         fhir:url [ fhir:v "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale"^^xsd:anyURI ] ;
         fhir:value [ fhir:v "An additional dose of MCV should be administered to HIV-infected children receiving HAART following immune reconstitution. If CD4+ T lymphocyte counts are monitored, an additional dose of MCV should be administered when immune reconstitution has been achieved, e.g. when the CD4+ T lymphocyte count reaches 20–25%. Where CD4+ T lymphocyte monitoring is not available, children should receive an additional dose of MCV 6–12 months after initiation of HAART.<br/>As a general rule, live vaccines should be given either simultaneously or at intervals of 4 weeks. An exception to this rule is OPV, which can be given at any time before or after measles vaccination without interference in the response to either vaccine" ]
       ] ) ;
       fhir:title [ fhir:v "Consider supplementary dose" ] ;
       fhir:condition ( [
         fhir:kind [ fhir:v "applicability" ] ;
         fhir:expression [
           fhir:language [ fhir:v "text/cql-identifier" ] ;
           fhir:expression [ fhir:v "No Supplementary Dose Administered" ]
         ]
       ] ) ;
       fhir:action ( [
         fhir:title [ fhir:v "Last Live Vaccine Administered Within 4 Weeks" ] ;
         fhir:description [ fhir:v "Should not vaccinate client for measles supplementary dose as live vaccine was administered in the last 4 weeks. Check for any vaccines due, and inform the caregiver of when to come back for supplementary dose." ] ;
         fhir:condition ( [
           fhir:kind [ fhir:v "applicability" ] ;
           fhir:expression [
             fhir:language [ fhir:v "text/cql-identifier" ] ;
             fhir:expression [ fhir:v "Last Live Vaccine Administered Within 4 Weeks" ]
           ]
         ] )
       ] [
         fhir:title [ fhir:v "Provide Measles Vaccine" ] ;
         fhir:description [ fhir:v "May vaccinate client for measles supplementary dose as supplementary dose was not administered, measles routine immunization schedule is complete and no live vaccine administered in the last 4 weeks. Check if one of the measles supplementary dose specific scenarios is applicable." ] ;
         fhir:condition ( [
           fhir:kind [ fhir:v "applicability" ] ;
           fhir:expression [
             fhir:language [ fhir:v "text/cql-identifier" ] ;
             fhir:expression [ fhir:v "Client Is Due For Supplementary Dose" ]
           ]
         ] ) ;
         fhir:definition [
           fhir:v "http://smart.who.int/immunizations-measles/ActivityDefinition/IMMZD2DTMeaslesMR"^^xsd:anyURI ;
           fhir:link <http://smart.who.int/immunizations-measles/ActivityDefinition/IMMZD2DTMeaslesMR>
         ] ;
         fhir:dynamicValue ( [
           fhir:path [ fhir:v "dispenseRequest.validityPeriod.start" ] ;
           fhir:expression [
             fhir:description [ fhir:v "Due date of the dose" ] ;
             fhir:language [ fhir:v "text/cql-identifier" ] ;
             fhir:expression [ fhir:v "MCV Supplementary Schedule Date" ]
           ]
         ] [
           fhir:path [ fhir:v "dispenseRequest.validityPeriod.end" ] ;
           fhir:expression [
             fhir:description [ fhir:v "Expiration date for MCV dose" ] ;
             fhir:language [ fhir:v "text/cql-identifier" ] ;
             fhir:expression [ fhir:v "MCV Supplementary Expiration Date" ]
           ]
         ] )
       ] )
     ] [
       fhir:title [ fhir:v "Supplementary Dose Administered" ] ;
       fhir:description [ fhir:v "Measles immunization schedule is complete. Measles supplementary dose was administered." ] ;
       fhir:condition ( [
         fhir:kind [ fhir:v "applicability" ] ;
         fhir:expression [
           fhir:language [ fhir:v "text/cql-identifier" ] ;
           fhir:expression [ fhir:v "Supplementary Dose Administered" ]
         ]
       ] )
     ] )
  ] ) . # 

# -------------------------------------------------------------------------------------

